HK1117536A - Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections - Google Patents

Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections Download PDF

Info

Publication number
HK1117536A
HK1117536A HK08108454.4A HK08108454A HK1117536A HK 1117536 A HK1117536 A HK 1117536A HK 08108454 A HK08108454 A HK 08108454A HK 1117536 A HK1117536 A HK 1117536A
Authority
HK
Hong Kong
Prior art keywords
bone
prevention
treatment
joint infections
phosphonated rifamycins
Prior art date
Application number
HK08108454.4A
Other languages
Chinese (zh)
Inventor
扬妮克．斯特凡．罗斯
斯特凡．西布拉
廷．康
法 阿德尔．拉菲
埃弗利娜．迪特里克
亚尼克．拉方丹
郎格．雷迪
Original Assignee
塔甘塔治疗公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 塔甘塔治疗公司 filed Critical 塔甘塔治疗公司
Publication of HK1117536A publication Critical patent/HK1117536A/en

Links

HK08108454.4A 2005-08-11 2006-08-11 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections HK1117536A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/707,145 2005-08-11

Publications (1)

Publication Number Publication Date
HK1117536A true HK1117536A (en) 2009-01-16

Family

ID=

Similar Documents

Publication Publication Date Title
IL189270A0 (en) Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
AU2007227398A8 (en) Compounds for the treatment of spinal muscular atrophy and other uses
IL257622B (en) Methods and compositions for the treatment of persistent infections
AU2003901008A0 (en) Composition for the treatment and prevention of bacterial infections
AU2005339139A8 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
AP2007004245A0 (en) Compounds and methods for the treatment or prevention of flavivirus infections
EP2324041A4 (en) Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
WO2006124713A3 (en) 4-biarylyl-1-phenylazetidin-2-ones
WO2007101161A8 (en) Methods and compositions for the treatment of gastrointestinal disorders
EP2097440A4 (en) Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections
IL186672A0 (en) Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections
EP1912630A4 (en) Compositions and methods for the reduction of post-operative pain
HK1117536A (en) Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
WO2006081350A8 (en) Methods and compositions for the diagnosis and treatment of schizophrenia
HK1117520A (en) Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections
HK1110530A (en) Methods and compositions for the treatment of pain
HK1130684A (en) Methods and compositions for the treatment and prevention of infections
HK1123939A (en) The use of bacillus pb6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases
AU2004906798A0 (en) Pharmaceutical composition for the treatment of skin conditions
HK1104476A (en) Pharmaceutical compositions and methods for peptide treatment
HK1109727A (en) Tetrodotoxin and its derivatives for the treatment of central-nervously derived neuropathic pain
HK1109560A (en) Tetrodotoxin and its derivatives for the treatment of peripheral-nervously derived neuropathic pain
HK1114021A (en) Tizanidine compositions and methods of treatment using the compositions
HK1111167A (en) Novel compounds derived from 5-thioxylose and therapeutic use thereof
AU2005902153A0 (en) Agent for the treatment of tissue disruption